Associated Papers
Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review.
Ditters IAM et al.
Biomolecules, 2023
37759814 (PubMed )
Supplement: biomolecules-13-01414-s001.zip › Supplementary_Table_S1.pdf
Late-onset myopathies: clinical features and diagnosis.
de Visser M
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology, 2020
High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa.
de Vries JM et al.
Molecular Genetics and Metabolism, 2010
Select a paper to view details